NASDAQ:ZYXI - Zynex Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.00
  • Forecasted Upside: 67.20 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$12.56
▲ +0.03 (0.24%)

This chart shows the closing price for ZYXI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Zynex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZYXI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZYXI

Analyst Price Target is $21.00
▲ +67.20% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Zynex in the last 3 months. The average price target is $21.00, with a high forecast of $22.50 and a low forecast of $19.50. The average price target represents a 67.20% upside from the last price of $12.56.

This chart shows the closing price for ZYXI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in Zynex. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/27/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/23/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/23/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/20/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/14/2021HC WainwrightReiterated RatingBuy$22.00High
7/30/2021HC WainwrightLower Price TargetBuy$25.00 ➝ $22.00High
7/16/2021Northland SecuritiesReiterated RatingBuy$22.50High
7/16/2021HC WainwrightReiterated RatingBuy$25.00High
7/16/2021B. RileyUpgradeNeutral ➝ Buy$19.00 ➝ $19.50High
3/15/2021Northland SecuritiesUpgradeMarket Perform ➝ OutperformN/A
3/9/2021Northland SecuritiesUpgradeMarket Perform ➝ Outperform$22.50High
2/26/2021B. RileyDowngradeBuy ➝ Neutral$19.00High
1/29/2021Piper SandlerDowngradeOverweight ➝ Neutral$28.00 ➝ $20.00High
1/28/2021Northland SecuritiesDowngradeOutperform ➝ Market Perform$22.50High
10/28/2020Northland SecuritiesReiterated RatingBuy$22.50High
9/14/2020HC WainwrightUpgradeNeutral ➝ BuyMedium
9/9/2020Northland SecuritiesUpgradeMarket Perform ➝ Outperform$22.50Medium
7/29/2020B. RileyUpgradeNeutral ➝ Buy$28.00Medium
7/29/2020Northland SecuritiesReiterated RatingHold$22.50High
7/29/2020HC WainwrightLower Price TargetNeutral$30.00 ➝ $25.00High
7/20/2020Piper SandlerInitiated CoverageOverweight$30.00Medium
7/13/2020B. RileyDowngradeBuy ➝ NeutralLow
7/10/2020HC WainwrightReiterated RatingNeutral$20.00 ➝ $30.00High
6/16/2020Northland SecuritiesDowngradeOutperform ➝ Market Perform$21.00High
5/29/2020B. RileyBoost Price TargetBuy$18.50 ➝ $25.50High
5/19/2020Northland SecuritiesReiterated RatingBuy$21.00Low
5/19/2020HC WainwrightDowngradeBuy ➝ Neutral$20.00Low
4/29/2020HC WainwrightReiterated RatingBuy$15.00 ➝ $20.00High
4/8/2020HC WainwrightReiterated RatingBuy$15.00High
4/1/2020Northland SecuritiesInitiated CoverageOutperform$15.00Low
3/30/2020B. RileyLower Price TargetBuy$20.50 ➝ $18.50High
2/26/2020HC WainwrightReiterated RatingBuy$13.00Low
2/21/2020B. RileyBoost Price TargetBuy$12.00 ➝ $19.75High
2/4/2020HC WainwrightReiterated RatingBuy$12.00Low
1/10/2020HC WainwrightReiterated RatingBuy$12.00Low
1/9/2020B. RileyReiterated RatingBuy$12.00Low
10/30/2019HC WainwrightReiterated RatingBuy$12.00High
10/22/2019B. RileyBoost Price TargetBuy$10.75 ➝ $12.00High
10/15/2019B. RileyReiterated RatingBuyLow
9/23/2019HC WainwrightReiterated RatingBuyLow
9/23/2019HC WainwrightInitiated CoverageBuy$12.00High
8/2/2019B. RileyBoost Price TargetBuy$9.00 ➝ $10.75Medium
2/22/2019B. RileyReiterated RatingBuyHigh
11/2/2018B. RileySet Price TargetBuy$7.00Low
10/10/2018B. RileyInitiated CoverageBuy$7.00Medium
8/21/2017Taglich BrothersReiterated RatingSpeculative BuyN/A
(Data available from 10/20/2016 forward)

News Sentiment Rating

0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 2 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
7/22/2021
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/20/2021
  • 2 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/20/2021

Current Sentiment

  • 2 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Zynex logo
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.
Read More

Today's Range

Now: $12.56
Low: $12.54
High: $12.90

50 Day Range

MA: $12.63
Low: $10.83
High: $14.81

52 Week Range

Now: $12.56
Low: $10.66
High: $22.89

Volume

118,620 shs

Average Volume

396,105 shs

Market Capitalization

$436.59 million

P/E Ratio

83.73

Dividend Yield

N/A

Beta

0.85

Frequently Asked Questions

What sell-side analysts currently cover shares of Zynex?

The following sell-side analysts have issued stock ratings on Zynex in the last twelve months: B. Riley, HC Wainwright, Northland Securities, Piper Sandler, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for ZYXI.

What is the current price target for Zynex?

4 Wall Street analysts have set twelve-month price targets for Zynex in the last year. Their average twelve-month price target is $21.00, suggesting a possible upside of 66.0%. Northland Securities has the highest price target set, predicting ZYXI will reach $22.50 in the next twelve months. B. Riley has the lowest price target set, forecasting a price of $19.50 for Zynex in the next year.
View the latest price targets for ZYXI.

What is the current consensus analyst rating for Zynex?

Zynex currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ZYXI will outperform the market and that investors should add to their positions of Zynex.
View the latest ratings for ZYXI.

What other companies compete with Zynex?

How do I contact Zynex's investor relations team?

Zynex's physical mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company's listed phone number is (866) 940-7030 and its investor relations email address is [email protected] The official website for Zynex is www.zynex.com.